208 related articles for article (PubMed ID: 22614210)
1. Percutaneous osteoplasty combined with radioiodine therapy as a treatment for bone metastasis developing after differentiated thyroid carcinoma.
Song HJ; Wu CG; Xue YL; Xu YH; Qiu ZL; Luo QY
Clin Nucl Med; 2012 Jun; 37(6):e129-33. PubMed ID: 22614210
[TBL] [Abstract][Full Text] [Related]
2. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
3. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma.
Van Tol KM; Hew JM; Jager PL; Vermey A; Dullaart RP; Links TP
Clin Endocrinol (Oxf); 2000 May; 52(5):653-9. PubMed ID: 10792347
[TBL] [Abstract][Full Text] [Related]
4. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
5. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
6. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer.
Qiu ZL; Song HJ; Xu YH; Luo QY
J Clin Endocrinol Metab; 2011 Oct; 96(10):3078-86. PubMed ID: 21795449
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
Liu YY; Stokkel MP; Morreau HA; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2008 Apr; 68(4):605-9. PubMed ID: 17986279
[TBL] [Abstract][Full Text] [Related]
9. [Embolization of skeletal metastases in patients with differentiated thyroid carcinoma].
Smit JW; Links TP; Hew JM; Goslings BM; Vielvoye GJ; Vermey A
Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1406-10. PubMed ID: 10923150
[TBL] [Abstract][Full Text] [Related]
10. Combination radiofrequency ablation and percutaneous osteoplasty for palliative treatment of painful extraspinal bone metastasis: a single-center experience.
Tian QH; Wu CG; Gu YF; He CJ; Li MH; Cheng YD
J Vasc Interv Radiol; 2014 Jul; 25(7):1094-100. PubMed ID: 24801500
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
12. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract][Full Text] [Related]
13. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of distant metastasis from differentiated thyroid carcinoma.
Huang IC; Chou FF; Liu RT; Tung SC; Chen JF; Kuo MC; Hsieh CJ; Wang PW
Clin Endocrinol (Oxf); 2012 Mar; 76(3):439-47. PubMed ID: 21950769
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
17. [Radioiodine therapy for thyroid cancer].
Misaki T
Nihon Rinsho; 2007 Nov; 65(11):2049-52. PubMed ID: 18018569
[TBL] [Abstract][Full Text] [Related]
18. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]